Why current drug adherence programs fail: addressing psychological risk factors of nonadherence

被引:9
|
作者
Arlt, Antje D. [1 ]
Nestoriuc, Yvonne [2 ,3 ]
Rief, Winfried [1 ]
机构
[1] Philipps Univ Marburg, Clin Psychol & Psychotherapy, Marburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Psychosomat Med & Psychotherapy, Hamburg, Germany
[3] Schon Clin Hamburg Eilbek, Hamburg, Germany
关键词
cognitive impairment; compliance; depression; doctor-patient relationship; fear of side-effects; illness acceptance; nonadherence; QUALITY-OF-LIFE; HEALTH BELIEF MODEL; MEDICATION ADHERENCE; COGNITIVE IMPAIRMENT; ILLNESS ACCEPTANCE; PATIENT ADHERENCE; ENDOCRINE THERAPY; IDENTIFY PATIENTS; BREAST-CANCER; OLDER-ADULTS;
D O I
10.1097/YCO.0000000000000345
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose of reviewTo provide an overview of a selection of largely neglected psychological risk factors for nonadherence, and to offer new approaches to improve medication adherence.Recent findingsCurrent adherence research and intervention programs focus on a few risk factors for nonadherence, such as complexity of the drug regimen. In addition, other important risk factors of nonadherence are neglected or insufficiently addressed. There is good evidence for the significant role of the quality of the patient-healthcare provider relationship. Other risk factors like the individual history of nonadherence, the lack of acceptance of having a treatable disorder, fear of side-effects, comorbid depression, and cognitive impairment have been broadly neglected in adherence programs, although they offer a powerful key to improve adherence-oriented interventions.SummaryCurrent research on determinants of nonadherence has focused on a few risk factors, while neglecting crucial psychological predictors of nonadherence. The personalized consideration of a multiplicity of risk factors offers a new basis for the development and evaluation of interventions to better promote adherence.
引用
收藏
页码:326 / 333
页数:8
相关论文
共 50 条
  • [21] Drug non-adherence in hypertensive patients in Morocco, and its associated risk factors
    Essayagh, Touria
    Essayagh, Meriem
    Essayagh, Sanah
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2021, 20 (04) : 324 - 330
  • [22] Tuberculosis in London: Prevalence of disease and risk factors for poor adherence, drug resistance, and relapse
    Story, A
    Roberts, W
    Hayward, AC
    THORAX, 2004, 59 : 36 - 36
  • [23] Psychological Factors and Cardiac Risk and Impact of Exercise Training Programs-A Review of Ochsner Studies
    Lavie, Carl J.
    Milani, Richard V.
    Artham, Surya M.
    Gilliland, Yvonne
    OCHSNER JOURNAL, 2007, 7 (04): : 167 - 172
  • [24] MEDICATION ADHERENCE AND RISK FACTORS FOR NONADHERENCE AMONG HIV POSITIVE PREGNANT WOMEN TAKING TENOFOVIR BASED FIXED DOSE COMBINATION REGIMEN IN NIGERIA
    Omonaiye, O.
    Agu, K. A.
    VALUE IN HEALTH, 2016, 19 (07) : A912 - A913
  • [25] A STRONG NONLINEAR RELATIONSHIP BETWEEN ADHERENCE WITH DRUG THERAPY AND CONTINUOUS RISK FACTORS IN PPI USERS
    Pedan, A.
    Lu, J.
    Varasteh, L. T.
    VALUE IN HEALTH, 2009, 12 (07) : A507 - A507
  • [26] Risk factors for dropout from psychological substance use disorder treatment programs in criminal justice settings
    Lantz, Lina
    Chang, Zheng
    Virtanen, Suvi
    DRUG AND ALCOHOL DEPENDENCE, 2024, 259
  • [27] Addressing multiple behavioral risk factors in primary care a synthesis of current knowledge and stakeholder dialogue sessions
    Pronk, NP
    Peek, CJ
    Goldstein, MG
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2004, 27 (02) : 4 - 17
  • [28] Psychological factors involved in adherence in people with high risk of Type 2 Diabetes Mellitus (HRDM2)
    Anarte Ortiz, Maria Teresa
    Varela Moreno, Esperanza
    ANUARIO DE PSICOLOGIA, 2021, 51 (03): : 166 - 176
  • [29] Risk factors for drug resistant tuberculosis in Leicestershire - poor adherence to treatment remains an important cause of resistance
    Pritchard, AJ
    Hayward, AC
    Monk, PN
    Neal, KR
    EPIDEMIOLOGY AND INFECTION, 2003, 130 (03): : 481 - 483
  • [30] Non-adherence and drug-related interruptions are risk factors for delays in completion of treatment for tuberculosis
    Pettit, A. C.
    Cummins, J.
    Kaltenbach, L. A.
    Sterling, T. R.
    Warkentin, J. V.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (04) : 486 - 492